Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Laparoscopic surgery, Loss of personal independence in daily activities, Menstruation irregular, Nausea, Pain
Clinical narrative: autonomic dysfunction/ autonomic injuries/ lightheadedness/ feel faint/ fainting/ headaches/ nausea/ vomiting/ neurological injuries; gynecologic injuries/ increased menstrual pain/ excruciating pain/ chronic pain/ menstrual dysfunction; gynecologic injuries/ menstrual irregularity/ menstrual dysfunction; unexplained bruising; autoimmune injury; This spontaneous report was received from a lawyer, regarding a case in litigation and refers to a female patient (pt), who was an adult at the time of report but whose age/age group at the time of events could not be established unequivocally (also reported as teenager prior to vaccination). The pt's concurrent conditions, medical history or concurrent medications were not reported. On an unknown date, at the age of 14 years old, the pt was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, anatomical location, lot # and expiry date were not provided) for prevention of cervical cancer, as consented by the pt's mother and recommended by a healthcare provider. On unknown dates, the pt sustained serious autoimmune, autonomic and gynecologic injuries as a result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccination. On unknown dates, the pt sustained serious and debilitating injuries, including but not limited to autonomic, autoimmune, and neurological injuries and resulting sequalae that the pt sustained as a result of receiving the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccine. The pt was a healthy active teenager who enjoyed participating in sports prior to receiving quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). On unknown dates following her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccination, the pt experienced lightheadedness, feeling faint, fainting, headaches, nausea, vomiting, unexplained bruising, increased menstrual pain, and menstrual irregularity. She was placed on a high dose of unspecified prescription birth control medications designed to stop her cycle to control her menstrual pain. The excruciating pain the pt experienced interfered with her ability to attend school on a regular basis. As the months progressed, so did the pt's symptoms. She was seen by multiple physicians and specialists for her complaints. She was prescribed medications and underwent laparoscopic surgery and a dilation and curettage (DC) to remove debris to treat her severe menstrual symptoms. The pt did not know and had no reason to know that the symptoms she was experiencing were caused by the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccine, as no information to the contrary was given to her by her medical providers. It was not until late 2021, that she began to suspect that quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was the cause of her symptoms and injuries. The pt's chronic and severe post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms included but were not limited to autonomic dysfunction, menstrual dysfunction, unexplained bruising, and chronic pain. The pt contended that her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injection caused her to develop serious and debilitating autoimmune, autonomic, and gynecologic injuries, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which were alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune disorder. As a proximate result of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), the pt suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and suffered severe and permanent emotional injuries, including pain and suffering. She also had a substantial fear of suffering additional and ongoing harms, including but not limited to being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, the pt suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. The outcome of the events was considered to be not recovered. The events were considered to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL).   Upon internal review, the event of autoimmune injuries was determined to be medically significant. All events were considered to be disabling by the reporter.